Replimune Group Inc

Stock Chart, Company Information, and Scan Results

$16.06(as of Oct 28, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Replimune Group Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$16.06
Ticker SymbolREPL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees465
CountyUSA
Market Cap$1,079.8M
EBIDTA-290.4M
10-Day Moving Average12.18
P/E Ratio-5.24
20-Day Moving Average12.55
Forward P/E Ratio0.00
50-Day Moving Average13.46
Earnings per Share-3.15
200-Day Moving Average9.20
Profit MarginUnknown
RSI70.35
Shares Outstanding94.2M
ATR1.04
52-Week High16.33
Volume7,265,391
52-Week Low1.50
Most Recent Support Level11.36
Book Value105.6M
Most Recent Resistance Level12.05
P/B Ratio14.73
Upper Keltner14.88
P/S RatioUnknown
Lower Keltner10.22
Debt-to-Equity Ratio1.06
Next Earnings DateUnknown
Cash Surplus146.9M
Next Ex-Dividend DateUnknown

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that expresses an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4. The company was founded in 2015 and is headquartered in Woburn, Massachusetts.

Replimune Group Inc In Our Stock Scanner

As of Oct 28, 2026
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.